Detalhe da pesquisa
1.
Understanding complex disease-related mechanisms: Rational therapies for Diamond-Blackfan anaemia.
Br J Haematol
; 204(5): 1598-1599, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485153
2.
HMGB1-mediated restriction of EPO signaling contributes to anemia of inflammation.
Blood
; 139(21): 3181-3193, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35040907
3.
Late-onset Pneumocystis jirovecii pneumonia post-allogeneic stem cell transplantation after time-dependent discontinuation of prophylaxis.
Eur J Haematol
; 112(3): 433-438, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37947314
4.
Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data.
Eur J Haematol
; 112(2): 301-309, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37830403
5.
A Primed Neutrophil Subset Predicts the Risk of Bloodstream Infections in Allogeneic Hematopoietic Stem-Cell Transplant Patients: A Prospective Study.
Clin Infect Dis
; 77(5): 752-760, 2023 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37157867
6.
Treatment-free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5-year analysis of DASFREE.
Br J Haematol
; 202(5): 942-952, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246588
7.
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment-free remission after failing the first attempt with imatinib: Treatment-free Remission Accomplished by Dasatinib (TRAD) study.
Br J Haematol
; 203(5): 781-791, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37697469
8.
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial.
Blood
; 138(21): 2042-2050, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407543
9.
Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up.
Haematologica
; 108(7): 1817-1826, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727396
10.
Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience.
Ann Hematol
; 102(4): 917-926, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36820907
11.
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission.
Eur J Haematol
; 111(4): 553-561, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37461810
12.
Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis.
Eur J Haematol
; 110(6): 618-625, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36732677
13.
Prognostic implication of pre-transplant FEV1 on long-term outcomes following allogeneic hematopoietic stem cell transplantation.
Eur J Haematol
; 111(5): 687-696, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491877
14.
Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantation.
Clin Chem Lab Med
; 61(6): 1005-1014, 2023 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36655501
15.
Weight loss post-allogeneic stem cell transplant is associated with increased transplant-related mortality.
Support Care Cancer
; 31(10): 564, 2023 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676349
16.
Defects in Bone and Bone Marrow in Inherited Anemias: the Chicken or the Egg.
Curr Osteoporos Rep
; 21(5): 527-539, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37436584
17.
BCR-ABL1 transcript doubling time as a predictor for treatment-free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase.
Br J Haematol
; 196(1): 136-145, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496035
18.
Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts.
Eur J Haematol
; 108(1): 61-72, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34606661
19.
Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen-A and -B mismatched donors.
Eur J Haematol
; 108(4): 288-297, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34905239
20.
Allogeneic hematopoietic stem cell transplantation in patients with therapy-related hematologic malignancies developing after multiple myeloma.
Eur J Haematol
; 108(5): 430-436, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35100661